We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing... Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing in development with ongoing clinical programs: AVTX-002, AVTX-007, and AVTX-006. Show more
Appointments include industry veterans Aaron Kantoff, Jonathan Goldman, and Samantha Truex as Independent DirectorsBoard of Director appointments in conjunction with Avalo’s recent acquisition of...
Acquired AVTX-009, Phase-2 ready anti-IL-1β mAb, in March 2024Increased cash position with private placement financing in March 2024 providing up to $185 million, including initial upfront...
Avalo acquires Phase 2-ready anti-IL-1β mAb, AVTX-009, through acquisition of AlmataBio, Inc. Topline results from planned Phase 2 trial in hidradenitis suppurativa expected in 2026Executed...
WAYNE, Pa. and ROCKVILLE, Md., Dec. 27, 2023 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced a 1-for-240 reverse stock split of the Company’s common stock, par value...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 4.26 | 36.4726027397 | 11.68 | 16.32 | 11.46 | 84127 | 13.47377887 | CS |
4 | -3.06 | -16.1052631579 | 19 | 22.47 | 11.1 | 304404 | 16.1004492 | CS |
12 | 11.33 | 245.770065076 | 4.61 | 34.46 | 4.0101 | 716683 | 19.34684681 | CS |
26 | -9.98 | -38.5030864198 | 25.92 | 34.46 | 3.9501 | 11223074 | 18.03156162 | CS |
52 | -696.86 | -97.7637485971 | 712.8 | 1130.4 | 3.9501 | 23586247 | 33.37290335 | CS |
156 | -672.86 | -97.6858304297 | 688.8 | 1711.2 | 3.9501 | 8976055 | 39.32072394 | CS |
260 | -672.86 | -97.6858304297 | 688.8 | 1711.2 | 3.9501 | 8976055 | 39.32072394 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions